L29163 ELECTROCARDIOGRAPHY

 

 

10/01/2010

 

Indications and Limitations of Coverage and/or Medical Necessity

 

• EKG services are covered diagnostic tests when there are documented signs and symptoms or other clinical indications for providing the service.

o Coverage includes the review and interpretation of EKG’s only by a physician.

o There is no coverage for EKG services when rendered as a screening test or as part of a routine examination unless performed as part of the one-time, “Welcome to Medicare” preventive physical examination under section 611 of the Medicare Prescription Drug, Improvement and Modernization Act of 2003.

• Electrocardiograms are indicated for diagnosis and patient management purposes involving symptoms of the

o Heart.

o Pericardium.

o Thoracic cavity.

o System diseases which produce cardiac abnormalities.

• Medicare will consider an EKG medically necessary in any of the following circumstances:

o Initial diagnostic workup for a patient that presents with complaints of symptoms such as

 Chest pain.

 Palpitations.

 Dyspnea.

 Dizziness.

 Syncope.

• Which may suggest a cardiac origin.

o Evaluation of a patient on a cardiac medication for a cardiac arrhythmia or other cardiac condition which affects the electrical conduction system of the heart (e.g., inotropics such as digoxin; antiarrhythmics such as Tambocor, Procainamide, or Quinidine; and antianginals such as Cardizem, Isordil, Corgard, Procardia, Inderal and Verapamil).

 The EKG is necessary to evaluate the effect of the cardiac medication on the patient’s

• Cardiac rhythm.

• Conduction system.

o Evaluation of a patient with a pacemaker with or without clinical findings (history or physical examination) that suggest possible pacemaker malfunction.

o Evaluation of a patient who has a significant cardiac arrhythmia or conduction disorder in which an EKG is necessary as part of the evaluation and management of the patient.

o These disorders may include, but are not limited to, the following:

 Complete Heart Block.

 Second Degree AV Block.

 Left Bundle Branch Block.

 Right Bundle Branch Block

 Paroxysmal VT.

 Atrial Fib/Flutter.

 Ventricular Fib/Flutter.

 Cardiac Arrest.

 Frequent PVCs.

 Frequent PACs.

 Wandering Atrial Pacemaker.

 Any other unspecified cardiac arrhythmia.

o Evaluation of a patient with known Coronary Artery Disease (CAD) and/or heart muscle disease that presents with symptoms such as

 Increasing shortness of breath (SOB).

 Palpitations.

 Angina.

o Evaluation of a patient’s response to a newly established therapy for

 Angina.

 Palpitations.

 Arrhythmias.

 SOB.

 Other cardiopulmonary disease process.

o Evaluation of patients after coronary artery revascularization by:

 Coronary Artery Bypass Grafting. (CABGs).

 Percutaneous Transluminal Coronary Angiography. (PTCA).

 Thrombolytic therapy. (e.g., TPA, Streptokinase, Urokinase).

 Stent placement.

o Evaluation of patients presenting with symptoms of a Myocardial Infarction (MI).

o Evaluation of other symptomatology which may indicate a cardiac origin especially in those patients who have a history of:

 An MI.

 CABG surgery.

 PTCA.

 patients who are being treated medically after:

• Positive stress test.

• Cardiac catherization.

o Pre-operative Evaluation of the patient when:

 Undergoing cardiac surgery such as:

• CABGs.

• Automatic implantable cardiac defibrillator.

• Pacemaker.

 the patient has a medical condition associated with a significant risk of serious cardiac arrhythmia and/or myocardial ischemia such as:

• Diabetes.

• History of MI.

• Angina pectoris.

• Aneurysm of heart wall.

• Chronic ischemic heart disease.

• Pericarditis.

• Valvular disease.

• Cardiomyopathy.

• Other

o Evaluation of a patient’s response to the administration of an agent known to result in cardiac or EKG abnormalities. (for patients with suspected, or at increased risk of developing, cardiovascular disease or dysfunction).

 Examples of these agents are antineoplastic drugs, lithium, tranquilizers, anticonvulsants, and antidepressant agents.

o When performed as a baseline evaluation prior to the initiation of an agent known to result in cardiac or EKG abnormalities. (An example of such an agent is verapamil.)

 

 

CPT/HCPCS Codes

 

93000 ELECTROCARDIOGRAM, ROUTINE ECG WITH AT LEAST 12 LEADS; WITH INTERPRETATION AND REPORT

93005 ELECTROCARDIOGRAM, ROUTINE ECG WITH AT LEAST 12 LEADS; TRACING ONLY, WITHOUT INTERPRETATION AND REPORT

93010 ELECTROCARDIOGRAM, ROUTINE ECG WITH AT LEAST 12 LEADS; INTERPRETATION AND REPORT ONLY

 

 

ICD-9 Codes that Support Medical Necessity

 

079.0 ADENOVIRUS INFECTION IN CONDITIONS CLASSIFIED ELSEWHERE AND OF UNSPECIFIED SITE

079.1 ECHO VIRUS INFECTION IN CONDITIONS CLASSIFIED ELSEWHERE AND OF UNSPECIFIED SITE

079.2 COXSACKIE VIRUS INFECTION IN CONDITIONS CLASSIFIED ELSEWHERE AND OF UNSPECIFIED SITE

079.3 RHINOVIRUS INFECTION IN CONDITIONS CLASSIFIED ELSEWHERE AND OF UNSPECIFIED SITE

079.4 HUMAN PAPILLOMAVIRUS IN CONDITIONS CLASSIFIED ELSEWHERE AND OF UNSPECIFIED SITE

079.50 RETROVIRUS UNSPECIFIED

079.51 HUMAN T-CELL LYMPHOTROPHIC VIRUS TYPE I [HTLV-I]

079.52 HUMAN T-CELL LYMPHOTROPHIC VIRUS TYPE II [HTLV-II]

079.53 HUMAN IMMUNODEFICIENCY VIRUS TYPE 2 [HIV-2]

079.59 OTHER SPECIFIED RETROVIRUS

079.6 RESPIRATORY SYNCYTIAL VIRUS (RSV)

079.81 HANTAVIRIS INFECTION

079.82 SARS-ASSOCIATED CORONAVIRUS INFECTION

079.83 PARVOVIRUSB19

079.88 OTHER SPECIFIED CHLAMYDIAL INFECTION

079.89 OTHER SPECIFIED VIRAL INFECTION

079.98 UNSPECIFIED CHLAMYDIAL INFECTION

079.99 UNSPECIFIED VIRAL INFECTION

240.0 GOITER SPECIFIED AS SIMPLE

240.9 GOITER UNSPECIFIED

241.0 NONTOXIC UNINODULAR GOITER

241.1 NONTOXIC MULTINODULAR GOITER

241.9 UNSPECIFIED NONTOXIC NODULAR GOITER

242.00 TOXIC DIFFUSE GOITER WITHOUT THYROTOXIC CRISIS OR STORM

242.01 TOXIC DIFFUSE GOITER WITH THYROTOXIC CRISIS OR STORM

242.10 TOXIC UNINODULAR GOITER WITHOUT THYROTOXIC CRISIS OR STORM

242.11 TOXIC UNINODULAR GOITER WITH THYROTOXIC CRISIS OR STORM

242.20 TOXIC MULTINODULAR GOITER WITHOUT THYROTOXIC CRISIS OR STORM

242.21 TOXIC MULTINODULAR GOITER WITH THYROTOXIC CRISIS OR STORM

242.30 TOXIC NODULAR GOITER UNSPECIFIED TYPE WITHOUT THYROTOXIC CRISIS OR STORM

242.31 TOXIC NODULAR GOITER UNSPECIFIED TYPE WITH THYROTOXIC CRISIS OR STORM

242.40 THYROTOXICOSIS FROM ECTOPIC THYROID NODULE WITHOUT THYROTOXIC CRISIS OR STORM

242.41 THYROTOXICOSIS FROM ECTOPIC THYROID NODULE WITH THYROTOXIC CRISIS OR STORM

242.80 THYROTOXICOSIS OF OTHER SPECIFIED ORIGIN WITHOUT THYROTOXIC CRISIS OR STORM

242.81 THYROTOXICOSIS OF OTHER SPECIFIED ORIGIN WITH THYROTOXIC CRISIS OR STORM

242.90 THYROTOXICOSIS WITHOUT GOITER OR OTHER CAUSE AND WITHOUT THYROTOXIC CRISIS OR STORM

242.91 THYROTOXICOSIS WITHOUT GOITER OR OTHER CAUSE WITH THYROTOXIC CRISIS OR STORM

243 CONGENITAL HYPOTHYROIDISM

244.0 POSTSURGICAL HYPOTHYROIDISM

244.1 OTHER POSTABLATIVE HYPOTHYROIDISM

244.2 IODINE HYPOTHYROIDISM

244.3 OTHER IATROGENIC HYPOTHYROIDISM

244.8 OTHER SPECIFIED ACQUIRED HYPOTHYROIDISM

244.9 UNSPECIFIED ACQUIRED HYPOTHYROIDISM

245.0 ACUTE THYROIDITIS

245.1 SUBACUTE THYROIDITIS

245.2 CHRONIC LYMPHOCYTIC THYROIDITIS

245.3 CHRONIC FIBROUS THYROIDITIS

245.4 IATROGENIC THYROIDITIS

245.8 OTHER AND UNSPECIFIED CHRONIC THYROIDITIS

245.9 THYROIDITIS UNSPECIFIED

246.0 DISORDERS OF THYROCALCITONIN SECRETION

246.1 DYSHORMONOGENIC GOITER

246.2 CYST OF THYROID

246.3 HEMORRHAGE AND INFARCTION OF THYROID

246.8 OTHER SPECIFIED DISORDERS OF THYROID

246.9 UNSPECIFIED DISORDER OF THYROID

250.00 DIABETES MELLITUS WITHOUT MENTION OF COMPLICATION, TYPE II OR UNSPECIFIED TYPE, NOT STATED AS UNCONTROLLED

250.01 DIABETES MELLITUS WITHOUT MENTION OF COMPLICATION, TYPE I [JUVENILE TYPE], NOT STATED AS UNCONTROLLED

250.02 DIABETES MELLITUS WITHOUT MENTION OF COMPLICATION, TYPE II OR UNSPECIFIED TYPE, UNCONTROLLED

250.03 DIABETES MELLITUS WITHOUT MENTION OF COMPLICATION, TYPE I [JUVENILE TYPE], UNCONTROLLED

250.10 DIABETES WITH KETOACIDOSIS, TYPE II OR UNSPECIFIED TYPE, NOT STATED AS UNCONTROLLED

250.11 DIABETES WITH KETOACIDOSIS, TYPE I [JUVENILE TYPE], NOT STATED AS UNCONTROLLED

250.12 DIABETES WITH KETOACIDOSIS, TYPE II OR UNSPECIFIED TYPE, UNCONTROLLED

250.13 DIABETES WITH KETOACIDOSIS, TYPE I [JUVENILE TYPE], UNCONTROLLED

250.20 DIABETES WITH HYPEROSMOLARITY, TYPE II OR UNSPECIFIED TYPE, NOT STATED AS UNCONTROLLED

250.21 DIABETES WITH HYPEROSMOLARITY, TYPE I [JUVENILE TYPE], NOT STATED AS UNCONTROLLED

250.22 DIABETES WITH HYPEROSMOLARITY, TYPE II OR UNSPECIFIED TYPE, UNCONTROLLED

250.23 DIABETES WITH HYPEROSMOLARITY, TYPE I [JUVENILE TYPE], UNCONTROLLED

250.30 DIABETES WITH OTHER COMA, TYPE II OR UNSPECIFIED TYPE, NOT STATED AS UNCONTROLLED

250.31 DIABETES WITH OTHER COMA, TYPE I [JUVENILE TYPE], NOT STATED AS UNCONTROLLED

250.32 DIABETES WITH OTHER COMA, TYPE II OR UNSPECIFIED TYPE, UNCONTROLLED

250.33 DIABETES WITH OTHER COMA, TYPE I [JUVENILE TYPE], UNCONTROLLED

250.40 DIABETES WITH RENAL MANIFESTATIONS, TYPE II OR UNSPECIFIED TYPE, NOT STATED AS UNCONTROLLED

250.41 DIABETES WITH RENAL MANIFESTATIONS, TYPE I [JUVENILE TYPE], NOT STATED AS UNCONTROLLED

250.42 DIABETES WITH RENAL MANIFESTATIONS, TYPE II OR UNSPECIFIED TYPE, UNCONTROLLED

250.43 DIABETES WITH RENAL MANIFESTATIONS, TYPE I [JUVENILE TYPE], UNCONTROLLED

250.50 DIABETES WITH OPHTHALMIC MANIFESTATIONS, TYPE II OR UNSPECIFIED TYPE, NOT STATED AS UNCONTROLLED

250.51 DIABETES WITH OPHTHALMIC MANIFESTATIONS, TYPE I [JUVENILE TYPE], NOT STATED AS UNCONTROLLED

250.52 DIABETES WITH OPHTHALMIC MANIFESTATIONS, TYPE II OR UNSPECIFIED TYPE, UNCONTROLLED

250.53 DIABETES WITH OPHTHALMIC MANIFESTATIONS, TYPE I [JUVENILE TYPE], UNCONTROLLED

250.60 DIABETES WITH NEUROLOGICAL MANIFESTATIONS, TYPE II OR UNSPECIFIED TYPE, NOT STATED AS UNCONTROLLED

250.61 DIABETES WITH NEUROLOGICAL MANIFESTATIONS, TYPE I [JUVENILE TYPE], NOT STATED AS UNCONTROLLED

250.62 DIABETES WITH NEUROLOGICAL MANIFESTATIONS, TYPE II OR UNSPECIFIED TYPE, UNCONTROLLED

250.63 DIABETES WITH NEUROLOGICAL MANIFESTATIONS, TYPE I [JUVENILE TYPE], UNCONTROLLED

250.70 DIABETES WITH PERIPHERAL CIRCULATORY DISORDERS, TYPE II OR UNSPECIFIED TYPE, NOT STATED AS UNCONTROLLED

250.71 DIABETES WITH PERIPHERAL CIRCULATORY DISORDERS, TYPE I [JUVENILE TYPE], NOT STATED AS UNCONTROLLED

250.72 DIABETES WITH PERIPHERAL CIRCULATORY DISORDERS, TYPE II OR UNSPECIFIED TYPE, UNCONTROLLED

250.73 DIABETES WITH PERIPHERAL CIRCULATORY DISORDERS, TYPE I [JUVENILE TYPE], UNCONTROLLED

250.80 DIABETES WITH OTHER SPECIFIED MANIFESTATIONS, TYPE II OR UNSPECIFIED TYPE, NOT STATED AS UNCONTROLLED

250.81 DIABETES WITH OTHER SPECIFIED MANIFESTATIONS, TYPE I [JUVENILE TYPE], NOT STATED AS UNCONTROLLED

250.82 DIABETES WITH OTHER SPECIFIED MANIFESTATIONS, TYPE II OR UNSPECIFIED TYPE, UNCONTROLLED

250.83 DIABETES WITH OTHER SPECIFIED MANIFESTATIONS, TYPE I [JUVENILE TYPE], UNCONTROLLED

250.90 DIABETES WITH UNSPECIFIED COMPLICATION, TYPE II OR UNSPECIFIED TYPE, NOT STATED AS UNCONTROLLED

250.91 DIABETES WITH UNSPECIFIED COMPLICATION, TYPE I [JUVENILE TYPE], NOT STATED AS UNCONTROLLED

250.92 DIABETES WITH UNSPECIFIED COMPLICATION, TYPE II OR UNSPECIFIED TYPE, UNCONTROLLED

250.93 DIABETES WITH UNSPECIFIED COMPLICATION, TYPE I [JUVENILE TYPE], UNCONTROLLED

276.0 HYPEROSMOLALITY AND/OR HYPERNATREMIA

276.1 HYPOSMOLALITY AND/OR HYPONATREMIA

276.2 ACIDOSIS

276.3 ALKALOSIS

276.4 MIXED ACID-BASE BALANCE DISORDER

276.50 VOLUME DEPLETION, UNSPECIFIED

276.51 DEHYDRATION

276.52 HYPOVOLEMIA

276.69 OTHER FLUID OVERLOAD

276.7 HYPERPOTASSEMIA

276.8 HYPOPOTASSEMIA

276.9 ELECTROLYTE AND FLUID DISORDERS NOT ELSEWHERE CLASSIFIED

277.00 CYSTIC FIBROSIS WITHOUT MECONIUM ILEUS

277.01 CYSTIC FIBROSIS WITH MECONIUM ILEUS

277.02 CYSTIC FIBROSIS WITH PULMONARY MANIFESTATIONS

277.03 CYSTIC FIBROSIS WITH GASTROINTESTINAL MANIFESTATIONS

277.09 CYSTIC FIBROSIS WITH OTHER MANIFESTATIONS

277.30 AMYLOIDOSIS, UNSPECIFIED

277.39 OTHER AMYLOIDOSIS

337.00 IDIOPATHIC PERIPHERAL AUTONOMIC NEUROPATHY, UNSPECIFIED

337.01 CAROTID SINUS SYNDROME

337.09 OTHER IDIOPATHIC PERIPHERAL AUTONOMIC NEUROPATHY

337.9 UNSPECIFIED DISORDER OF AUTONOMIC NERVOUS SYSTEM

390 RHEUMATIC FEVER WITHOUT HEART INVOLVEMENT

391.0 ACUTE RHEUMATIC PERICARDITIS

391.1 ACUTE RHEUMATIC ENDOCARDITIS

391.2 ACUTE RHEUMATIC MYOCARDITIS

391.8 OTHER ACUTE RHEUMATIC HEART DISEASE

391.9 ACUTE RHEUMATIC HEART DISEASE UNSPECIFIED

392.0 RHEUMATIC CHOREA WITH HEART INVOLVEMENT

392.9 RHEUMATIC CHOREA WITHOUT HEART INVOLVEMENT

393 CHRONIC RHEUMATIC PERICARDITIS

394.0 MITRAL STENOSIS

394.1 RHEUMATIC MITRAL INSUFFICIENCY

394.2 MITRAL STENOSIS WITH INSUFFICIENCY

394.9 OTHER AND UNSPECIFIED MITRAL VALVE DISEASES

395.0 RHEUMATIC AORTIC STENOSIS

395.1 RHEUMATIC AORTIC INSUFFICIENCY

395.2 RHEUMATIC AORTIC STENOSIS WITH INSUFFICIENCY

395.9 OTHER AND UNSPECIFIED RHEUMATIC AORTIC DISEASES

396.0 MITRAL VALVE STENOSIS AND AORTIC VALVE STENOSIS

396.1 MITRAL VALVE STENOSIS AND AORTIC VALVE INSUFFICIENCY

396.2 MITRAL VALVE INSUFFICIENCY AND AORTIC VALVE STENOSIS

396.3 MITRAL VALVE INSUFFICIENCY AND AORTIC VALVE INSUFFICIENCY

396.8 MULTIPLE INVOLVEMENT OF MITRAL AND AORTIC VALVES

396.9 MITRAL AND AORTIC VALVE DISEASES UNSPECIFIED

397.0 DISEASES OF TRICUSPID VALVE

397.1 RHEUMATIC DISEASES OF PULMONARY VALVE

397.9 RHEUMATIC DISEASES OF ENDOCARDIUM VALVE UNSPECIFIED

398.0 RHEUMATIC MYOCARDITIS

398.90 RHEUMATIC HEART DISEASE UNSPECIFIED

398.91 RHEUMATIC HEART FAILURE (CONGESTIVE)

398.99 OTHER RHEUMATIC HEART DISEASES

401.0 MALIGNANT ESSENTIAL HYPERTENSION

401.1 BENIGN ESSENTIAL HYPERTENSION

401.9 UNSPECIFIED ESSENTIAL HYPERTENSION

402.00 MALIGNANT HYPERTENSIVE HEART DISEASE WITHOUT HEART FAILURE

402.01 MALIGNANT HYPERTENSIVE HEART DISEASE WITH HEART FAILURE

402.10 BENIGN HYPERTENSIVE HEART DISEASE WITHOUT HEART FAILURE

402.11 BENIGN HYPERTENSIVE HEART DISEASE WITH HEART FAILURE

402.90 UNSPECIFIED HYPERTENSIVE HEART DISEASE WITHOUT HEART FAILURE

402.91 UNSPECIFIED HYPERTENSIVE HEART DISEASE WITH HEART FAILURE

403.00 HYPERTENSIVE CHRONIC KIDNEY DISEASE, MALIGNANT, WITH CHRONIC KIDNEY DISEASE STAGE I THROUGH STAGE IV, OR UNSPECIFIED

403.01 HYPERTENSIVE CHRONIC KIDNEY DISEASE, MALIGNANT, WITH CHRONIC KIDNEY DISEASE STAGE V OR END STAGE RENAL DISEASE

403.10 HYPERTENSIVE CHRONIC KIDNEY DISEASE, BENIGN, WITH CHRONIC KIDNEY DISEASE STAGE I THROUGH STAGE IV, OR UNSPECIFIED

403.11 HYPERTENSIVE CHRONIC KIDNEY DISEASE, BENIGN, WITH CHRONIC KIDNEY DISEASE STAGE V OR END STAGE RENAL DISEASE

403.90 HYPERTENSIVE CHRONIC KIDNEY DISEASE, UNSPECIFIED, WITH CHRONIC KIDNEY DISEASE STAGE I THROUGH STAGE IV, OR UNSPECIFIED

403.91 HYPERTENSIVE CHRONIC KIDNEY DISEASE, UNSPECIFIED, WITH CHRONIC KIDNEY DISEASE STAGE V OR END STAGE RENAL DISEASE

404.00 HYPERTENSIVE HEART AND CHRONIC KIDNEY DISEASE, MALIGNANT, WITHOUT HEART FAILURE AND WITH CHRONIC KIDNEY DISEASE STAGE I THROUGH STAGE IV, OR UNSPECIFIED

404.01 HYPERTENSIVE HEART AND CHRONIC KIDNEY DISEASE, MALIGNANT, WITH HEART FAILURE AND WITH CHRONIC KIDNEY DISEASE STAGE I THROUGH STAGE IV, OR UNSPECIFIED

404.02 HYPERTENSIVE HEART AND CHRONIC KIDNEY DISEASE, MALIGNANT, WITHOUT HEART FAILURE AND WITH CHRONIC KIDNEY DISEASE STAGE V OR END STAGE RENAL DISEASE

404.03 HYPERTENSIVE HEART AND CHRONIC KIDNEY DISEASE, MALIGNANT, WITH HEART FAILURE AND WITH CHRONIC KIDNEY DISEASE STAGE V OR END STAGE RENAL DISEASE

404.10 HYPERTENSIVE HEART AND CHRONIC KIDNEY DISEASE, BENIGN, WITHOUT HEART FAILURE AND WITH CHRONIC KIDNEY DISEASE STAGE I THROUGH STAGE IV, OR UNSPECIFIED

404.11 HYPERTENSIVE HEART AND CHRONIC KIDNEY DISEASE, BENIGN, WITH HEART FAILURE AND WITH CHRONIC KIDNEY DISEASE STAGE I THROUGH STAGE IV, OR UNSPECIFIED

404.12 HYPERTENSIVE HEART AND CHRONIC KIDNEY DISEASE, BENIGN, WITHOUT HEART FAILURE AND WITH CHRONIC KIDNEY DISEASE STAGE V OR END STAGE RENAL DISEASE

404.13 HYPERTENSIVE HEART AND CHRONIC KIDNEY DISEASE, BENIGN, WITH HEART FAILURE AND CHRONIC KIDNEY DISEASE STAGE V OR END STAGE RENAL DISEASE

404.90 HYPERTENSIVE HEART AND CHRONIC KIDNEY DISEASE, UNSPECIFIED, WITHOUT HEART FAILURE AND WITH CHRONIC KIDNEY DISEASE STAGE I THROUGH STAGE IV, OR UNSPECIFIED

404.91 HYPERTENSIVE HEART AND CHRONIC KIDNEY DISEASE, UNSPECIFIED, WITH HEART FAILURE AND WITH CHRONIC KIDNEY DISEASE STAGE I THROUGH STAGE IV, OR UNSPECIFIED

404.92 HYPERTENSIVE HEART AND CHRONIC KIDNEY DISEASE, UNSPECIFIED, WITHOUT HEART FAILURE AND WITH CHRONIC KIDNEY DISEASE STAGE V OR END STAGE RENAL DISEASE

404.93 HYPERTENSIVE HEART AND CHRONIC KIDNEY DISEASE, UNSPECIFIED, WITH HEART FAILURE AND CHRONIC KIDNEY DISEASE STAGE V OR END STAGE RENAL DISEASE

405.01 MALIGNANT RENOVASCULAR HYPERTENSION

405.09 OTHER MALIGNANT SECONDARY HYPERTENSION

405.11 BENIGN RENOVASCULAR HYPERTENSION

405.19 OTHER BENIGN SECONDARY HYPERTENSION

405.91 UNSPECIFIED RENOVASCULAR HYPERTENSION

405.99 OTHER UNSPECIFIED SECONDARY HYPERTENSION

410.00 ACUTE MYOCARDIAL INFARCTION OF ANTEROLATERAL WALL EPISODE OF CARE UNSPECIFIED

410.01 ACUTE MYOCARDIAL INFARCTION OF ANTEROLATERAL WALL INITIAL EPISODE OF CARE

410.02 ACUTE MYOCARDIAL INFARCTION OF ANTEROLATERAL WALL SUBSEQUENT EPISODE OF CARE

410.10 ACUTE MYOCARDIAL INFARCTION OF OTHER ANTERIOR WALL EPISODE OF CARE UNSPECIFIED

410.11 ACUTE MYOCARDIAL INFARCTION OF OTHER ANTERIOR WALL INITIAL EPISODE OF CARE

410.12 ACUTE MYOCARDIAL INFARCTION OF OTHER ANTERIOR WALL SUBSEQUENT EPISODE OF CARE

410.20 ACUTE MYOCARDIAL INFARCTION OF INFEROLATERAL WALL EPISODE OF CARE UNSPECIFIED

410.21 ACUTE MYOCARDIAL INFARCTION OF INFEROLATERAL WALL INITIAL EPISODE OF CARE

410.22 ACUTE MYOCARDIAL INFARCTION OF INFEROLATERAL WALL SUBSEQUENT EPISODE OF CARE

410.30 ACUTE MYOCARDIAL INFARCTION OF INFEROPOSTERIOR WALL EPISODE OF CARE UNSPECIFIED

410.31 ACUTE MYOCARDIAL INFARCTION OF INFEROPOSTERIOR WALL INITIAL EPISODE OF CARE

410.32 ACUTE MYOCARDIAL INFARCTION OF INFEROPOSTERIOR WALL SUBSEQUENT EPISODE OF CARE

410.40 ACUTE MYOCARDIAL INFARCTION OF OTHER INFERIOR WALL EPISODE OF CARE UNSPECIFIED

410.41 ACUTE MYOCARDIAL INFARCTION OF OTHER INFERIOR WALL INITIAL EPISODE OF CARE

410.42 ACUTE MYOCARDIAL INFARCTION OF OTHER INFERIOR WALL SUBSEQUENT EPISODE OF CARE

410.50 ACUTE MYOCARDIAL INFARCTION OF OTHER LATERAL WALL EPISODE OF CARE UNSPECIFIED

410.51 ACUTE MYOCARDIAL INFARCTION OF OTHER LATERAL WALL INITIAL EPISODE OF CARE

410.52 ACUTE MYOCARDIAL INFARCTION OF OTHER LATERAL WALL SUBSEQUENT EPISODE OF CARE

410.60 TRUE POSTERIOR WALL INFARCTION EPISODE OF CARE UNSPECIFIED

410.61 TRUE POSTERIOR WALL INFARCTION INITIAL EPISODE OF CARE

410.62 TRUE POSTERIOR WALL INFARCTION SUBSEQUENT EPISODE OF CARE

410.70 SUBENDOCARDIAL INFARCTION EPISODE OF CARE UNSPECIFIED

410.71 SUBENDOCARDIAL INFARCTION INITIAL EPISODE OF CARE

410.72 SUBENDOCARDIAL INFARCTION SUBSEQUENT EPISODE OF CARE

410.80 ACUTE MYOCARDIAL INFARCTION OF OTHER SPECIFIED SITES EPISODE OF CARE UNSPECIFIED

410.81 ACUTE MYOCARDIAL INFARCTION OF OTHER SPECIFIED SITES INITIAL EPISODE OF CARE

410.82 ACUTE MYOCARDIAL INFARCTION OF OTHER SPECIFIED SITES SUBSEQUENT EPISODE OF CARE

410.90 ACUTE MYOCARDIAL INFARCTION OF UNSPECIFIED SITE EPISODE OF CARE UNSPECIFIED

410.91 ACUTE MYOCARDIAL INFARCTION OF UNSPECIFIED SITE INITIAL EPISODE OF CARE

410.92 ACUTE MYOCARDIAL INFARCTION OF UNSPECIFIED SITE SUBSEQUENT EPISODE OF CARE

411.0 POSTMYOCARDIAL INFARCTION SYNDROME

411.1 INTERMEDIATE CORONARY SYNDROME

411.81 ACUTE CORONARY OCCLUSION WITHOUT MYOCARDIAL INFARCTION

411.89 OTHER ACUTE AND SUBACUTE FORMS OF ISCHEMIC HEART DISEASE OTHER

412 OLD MYOCARDIAL INFARCTION

413.0 ANGINA DECUBITUS

413.1 PRINZMETAL ANGINA

413.9 OTHER AND UNSPECIFIED ANGINA PECTORIS

414.00 CORONARY ATHEROSCLEROSIS OF UNSPECIFIED TYPE OF VESSEL NATIVE OR GRAFT

414.01 CORONARY ATHEROSCLEROSIS OF NATIVE CORONARY ARTERY

414.02 CORONARY ATHEROSCLEROSIS OF AUTOLOGOUS VEIN BYPASS GRAFT

414.03 CORONARY ATHEROSCLEROSIS OF NONAUTOLOGOUS BIOLOGICAL BYPASS GRAFT

414.04 CORONARY ATHEROSCLEROSIS OF ARTERY BYPASS GRAFT

414.05 CORONARY ATHEROSCLEROSIS OF UNSPECIFIED BYPASS GRAFT

414.06 CORONARY ATHEROSCLEROSIS OF NATIVE CORONARY ARTERY OF TRANSPLANTED HEART

414.07 CORONARY ATHEROSCLEROSIS OF BYPASS GRAFT (ARTERY) (VEIN) OF TRANSPLANTED HEART

414.10 ANEURYSM OF HEART (WALL)

414.11 ANEURYSM OF CORONARY VESSELS

414.12 DISSECTION OF CORONARY ARTERY

414.19 OTHER ANEURYSM OF HEART

414.2 CHRONIC TOTAL OCCLUSION OF CORONARY ARTERY

414.3 CORONARY ATHEROSCLEROSIS DUE TO LIPID RICH PLAQUE

414.8 OTHER SPECIFIED FORMS OF CHRONIC ISCHEMIC HEART DISEASE

414.9 CHRONIC ISCHEMIC HEART DISEASE UNSPECIFIED

415.0 ACUTE COR PULMONALE

415.11 IATROGENIC PULMONARY EMBOLISM AND INFARCTION

415.12 SEPTIC PULMONARY EMBOLISM

415.19 OTHER PULMONARY EMBOLISM AND INFARCTION

416.0 PRIMARY PULMONARY HYPERTENSION

416.1 KYPHOSCOLIOTIC HEART DISEASE

416.2 CHRONIC PULMONARY EMBOLISM

416.8 OTHER CHRONIC PULMONARY HEART DISEASES

416.9 CHRONIC PULMONARY HEART DISEASE UNSPECIFIED

417.0 ARTERIOVENOUS FISTULA OF PULMONARY VESSELS

417.1 ANEURYSM OF PULMONARY ARTERY

417.8 OTHER SPECIFIED DISEASES OF PULMONARY CIRCULATION

417.9 UNSPECIFIED DISEASE OF PULMONARY CIRCULATION

420.0 ACUTE PERICARDITIS IN DISEASES CLASSIFIED ELSEWHERE

420.90 ACUTE PERICARDITIS UNSPECIFIED

420.91 ACUTE IDIOPATHIC PERICARDITIS

420.99 OTHER ACUTE PERICARDITIS

421.0 ACUTE AND SUBACUTE BACTERIAL ENDOCARDITIS

421.1 ACUTE AND SUBACUTE INFECTIVE ENDOCARDITIS IN DISEASES CLASSIFIED ELSEWHERE

421.9 ACUTE ENDOCARDITIS UNSPECIFIED

422.0 ACUTE MYOCARDITIS IN DISEASES CLASSIFIED ELSEWHERE

422.90 ACUTE MYOCARDITIS UNSPECIFIED

422.91 IDIOPATHIC MYOCARDITIS

422.92 SEPTIC MYOCARDITIS

422.93 TOXIC MYOCARDITIS

422.99 OTHER ACUTE MYOCARDITIS

423.0 HEMOPERICARDIUM

423.1 ADHESIVE PERICARDITIS

423.2 CONSTRICTIVE PERICARDITIS

423.3 CARDIAC TAMPONADE

423.8 OTHER SPECIFIED DISEASES OF PERICARDIUM

423.9 UNSPECIFIED DISEASE OF PERICARDIUM

424.0 MITRAL VALVE DISORDERS

424.1 AORTIC VALVE DISORDERS

424.2 TRICUSPID VALVE DISORDERS SPECIFIED AS NONRHEUMATIC

424.3 PULMONARY VALVE DISORDERS

424.90 ENDOCARDITIS VALVE UNSPECIFIED UNSPECIFIED CAUSE

424.91 ENDOCARDITIS IN DISEASES CLASSIFIED ELSEWHERE

424.99 OTHER ENDOCARDITIS VALVE UNSPECIFIED

425.0 ENDOMYOCARDIAL FIBROSIS

425.1 HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY

425.2 OBSCURE CARDIOMYOPATHY OF AFRICA

425.3 ENDOCARDIAL FIBROELASTOSIS

425.4 OTHER PRIMARY CARDIOMYOPATHIES

425.5 ALCOHOLIC CARDIOMYOPATHY

425.7 NUTRITIONAL AND METABOLIC CARDIOMYOPATHY

425.8 CARDIOMYOPATHY IN OTHER DISEASES CLASSIFIED ELSEWHERE

425.9 SECONDARY CARDIOMYOPATHY UNSPECIFIED

426.0 ATRIOVENTRICULAR BLOCK COMPLETE

426.10 ATRIOVENTRICULAR BLOCK UNSPECIFIED

426.11 FIRST DEGREE ATRIOVENTRICULAR BLOCK

426.12 MOBITZ (TYPE) II ATRIOVENTRICULAR BLOCK

426.13 OTHER SECOND DEGREE ATRIOVENTRICULAR BLOCK

426.2 LEFT BUNDLE BRANCH HEMIBLOCK

426.3 OTHER LEFT BUNDLE BRANCH BLOCK

426.4 RIGHT BUNDLE BRANCH BLOCK

426.50 BUNDLE BRANCH BLOCK UNSPECIFIED

426.51 RIGHT BUNDLE BRANCH BLOCK AND LEFT POSTERIOR FASCICULAR BLOCK

426.52 RIGHT BUNDLE BRANCH BLOCK AND LEFT ANTERIOR FASCICULAR BLOCK

426.53 OTHER BILATERAL BUNDLE BRANCH BLOCK

426.54 TRIFASCICULAR BLOCK

426.6 OTHER HEART BLOCK

426.7 ANOMALOUS ATRIOVENTRICULAR EXCITATION

426.81 LOWN-GANONG-LEVINE SYNDROME

426.82 LONG QT SYNDROME

426.89 OTHER SPECIFIED CONDUCTION DISORDERS

426.9 CONDUCTION DISORDER UNSPECIFIED

427.0 PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA

427.1 PAROXYSMAL VENTRICULAR TACHYCARDIA

427.2 PAROXYSMAL TACHYCARDIA UNSPECIFIED

427.31 ATRIAL FIBRILLATION

427.32 ATRIAL FLUTTER

427.41 VENTRICULAR FIBRILLATION

427.42 VENTRICULAR FLUTTER

427.5 CARDIAC ARREST

427.60 PREMATURE BEATS UNSPECIFIED

427.61 SUPRAVENTRICULAR PREMATURE BEATS

427.69 OTHER PREMATURE BEATS

427.81 SINOATRIAL NODE DYSFUNCTION

427.89 OTHER SPECIFIED CARDIAC DYSRHYTHMIAS

427.9 CARDIAC DYSRHYTHMIA UNSPECIFIED

428.0 CONGESTIVE HEART FAILURE UNSPECIFIED

428.1 LEFT HEART FAILURE

428.20 UNSPECIFIED SYSTOLIC HEART FAILURE

428.21 ACUTE SYSTOLIC HEART FAILURE

428.22 CHRONIC SYSTOLIC HEART FAILURE

428.23 ACUTE ON CHRONIC SYSTOLIC HEART FAILURE

428.30 UNSPECIFIED DIASTOLIC HEART FAILURE

428.31 ACUTE DIASTOLIC HEART FAILURE

428.32 CHRONIC DIASTOLIC HEART FAILURE

428.33 ACUTE ON CHRONIC DIASTOLIC HEART FAILURE

428.40 UNSPECIFIED COMBINED SYSTOLIC AND DIASTOLIC HEART FAILURE

428.41 ACUTE COMBINED SYSTOLIC AND DIASTOLIC HEART FAILURE

428.42 CHRONIC COMBINED SYSTOLIC AND DIASTOLIC HEART FAILURE

428.43 ACUTE ON CHRONIC COMBINED SYSTOLIC AND DIASTOLIC HEART FAILURE

428.9 HEART FAILURE UNSPECIFIED

429.0 MYOCARDITIS UNSPECIFIED

429.1 MYOCARDIAL DEGENERATION

429.2 CARDIOVASCULAR DISEASE UNSPECIFIED

429.3 CARDIOMEGALY

429.4 FUNCTIONAL DISTURBANCES FOLLOWING CARDIAC SURGERY

429.5 RUPTURE OF CHORDAE TENDINEAE

429.6 RUPTURE OF PAPILLARY MUSCLE

429.71 CERTAIN SEQUELAE OF MYOCARDIAL INFARCTION NOT ELSEWHERE CLASSIFIED ACQUIRED CARDIAC SEPTAL DEFECT

429.79 CERTAIN SEQUELAE OF MYOCARDIAL INFARCTION NOT ELSEWHERE CLASSIFIED OTHER

429.81 OTHER DISORDERS OF PAPILLARY MUSCLE

429.82 HYPERKINETIC HEART DISEASE

429.83 TAKOTSUBO SYNDROME

429.89 OTHER ILL-DEFINED HEART DISEASES

429.9 HEART DISEASE UNSPECIFIED

435.9 UNSPECIFIED TRANSIENT CEREBRAL ISCHEMIA

436 ACUTE BUT ILL-DEFINED CEREBROVASCULAR DISEASE

440.0 ATHEROSCLEROSIS OF AORTA

440.1 ATHEROSCLEROSIS OF RENAL ARTERY

440.20 ATHEROSCLEROSIS OF NATIVE ARTERIES OF THE EXTREMITIES UNSPECIFIED

440.21 ATHEROSCLEROSIS OF NATIVE ARTERIES OF THE EXTREMITIES WITH INTERMITTENT CLAUDICATION

440.22 ATHEROSCLEROSIS OF NATIVE ARTERIES OF THE EXTREMITIES WITH REST PAIN

440.23 ATHEROSCLEROSIS OF NATIVE ARTERIES OF THE EXTREMITIES WITH ULCERATION

440.24 ATHEROSCLEROSIS OF NATIVE ARTERIES OF THE EXTREMITIES WITH GANGRENE

440.29 OTHER ATHEROSCLEROSIS OF NATIVE ARTERIES OF THE EXTREMITIES

440.30 ATHEROSCLEROSIS OF UNSPECIFIED BYPASS GRAFT OF THE EXTREMITIES

440.31 ATHEROSCLEROSIS OF AUTOLOGOUS VEIN BYPASS GRAFT OF THE EXTREMITIES

440.32 ATHEROSCLEROSIS OF NONAUTOLOGOUS BIOLOGICAL BYPASS GRAFT OF THE EXTREMITIES

440.4 CHRONIC TOTAL OCCLUSION OF ARTERY OF THE EXTREMITIES

440.8 ATHEROSCLEROSIS OF OTHER SPECIFIED ARTERIES

440.9 GENERALIZED AND UNSPECIFIED ATHEROSCLEROSIS

441.00 DISSECTION OF AORTA ANEURYSM UNSPECIFIED SITE

441.01 DISSECTION OF AORTA THORACIC

441.02 DISSECTION OF AORTA ABDOMINAL

441.03 DISSECTION OF AORTA THORACOABDOMINAL

441.1 THORACIC ANEURYSM RUPTURED

441.2 THORACIC ANEURYSM WITHOUT RUPTURE

441.3 ABDOMINAL ANEURYSM RUPTURED

441.4 ABDOMINAL ANEURYSM WITHOUT RUPTURE

441.5 AORTIC ANEURYSM OF UNSPECIFIED SITE RUPTURED

441.6 THORACOABDOMINAL ANEURYSM RUPTURED

441.7 THORACOABDOMINAL ANEURYSM WITHOUT RUPTURE

441.9 AORTIC ANEURYSM OF UNSPECIFIED SITE WITHOUT RUPTURE

442.0 ANEURYSM OF ARTERY OF UPPER EXTREMITY

442.1 ANEURYSM OF RENAL ARTERY

442.2 ANEURYSM OF ILIAC ARTERY

442.3 ANEURYSM OF ARTERY OF LOWER EXTREMITY

442.81 ANEURYSM OF ARTERY OF NECK

442.82 ANEURYSM OF SUBCLAVIAN ARTERY

442.83 ANEURYSM OF SPLENIC ARTERY

442.84 ANEURYSM OF OTHER VISCERAL ARTERY

442.89 ANEURYSM OF OTHER SPECIFIED SITE

442.9 OTHER ANEURYSM OF UNSPECIFIED SITE

443.0 RAYNAUD'S SYNDROME

443.1 THROMBOANGIITIS OBLITERANS (BUERGER'S DISEASE)

443.21 DISSECTION OF CAROTID ARTERY

443.22 DISSECTION OF ILIAC ARTERY

443.23 DISSECTION OF RENAL ARTERY

443.24 DISSECTION OF VERTEBRAL ARTERY

443.29 DISSECTION OF OTHER ARTERY

443.81 PERIPHERAL ANGIOPATHY IN DISEASES CLASSIFIED ELSEWHERE

443.82 ERYTHROMELALGIA

443.89 OTHER PERIPHERAL VASCULAR DISEASE

443.9 PERIPHERAL VASCULAR DISEASE UNSPECIFIED

444.0 EMBOLISM AND THROMBOSIS OF ABDOMINAL AORTA

444.1 EMBOLISM AND THROMBOSIS OF THORACIC AORTA

444.21 ARTERIAL EMBOLISM AND THROMBOSIS OF UPPER EXTREMITY

444.22 ARTERIAL EMBOLISM AND THROMBOSIS OF LOWER EXTREMITY

444.81 EMBOLISM AND THROMBOSIS OF ILIAC ARTERY

444.89 EMBOLISM AND THROMBOSIS OF OTHER ARTERY

444.9 EMBOLISM AND THROMBOSIS OF UNSPECIFIED ARTERY

445.01 ATHEROEMBOLISM OF UPPER EXTREMITY

445.02 ATHEROEMBOLISM OF LOWER EXTREMITY

445.81 ATHEROEMBOLISM OF KIDNEY

445.89 ATHEROEMBOLISM OF OTHER SITE

446.0 POLYARTERITIS NODOSA

446.1 ACUTE FEBRILE MUCOCUTANEOUS LYMPH NODE SYNDROME (MCLS)

446.20 HYPERSENSITIVITY ANGIITIS UNSPECIFIED

446.21 GOODPASTURE'S SYNDROME

446.29 OTHER SPECIFIED HYPERSENSITIVITY ANGIITIS

446.3 LETHAL MIDLINE GRANULOMA

446.4 WEGENER'S GRANULOMATOSIS

446.5 GIANT CELL ARTERITIS

446.6 THROMBOTIC MICROANGIOPATHY

446.7 TAKAYASU'S DISEASE

447.0 ARTERIOVENOUS FISTULA ACQUIRED

447.1 STRICTURE OF ARTERY

447.2 RUPTURE OF ARTERY

447.3 HYPERPLASIA OF RENAL ARTERY

447.4 CELIAC ARTERY COMPRESSION SYNDROME

447.5 NECROSIS OF ARTERY

447.6 ARTERITIS UNSPECIFIED

447.70 AORTIC ECTASIA, UNSPECIFIED SITE

447.71 THORACIC AORTIC ECTASIA

447.72 ABDOMINAL AORTIC ECTASIA

447.73 THORACOABDOMINAL AORTIC ECTASIA

447.8 OTHER SPECIFIED DISORDERS OF ARTERIES AND ARTERIOLES

447.9 UNSPECIFIED DISORDERS OF ARTERIES AND ARTERIOLES

448.0 HEREDITARY HEMORRHAGIC TELANGIECTASIA

448.1 NEVUS NON-NEOPLASTIC

448.9 OTHER AND UNSPECIFIED CAPILLARY DISEASES

668.10 CARDIAC COMPLICATIONS OF ANESTHESIA OR OTHER SEDATION IN LABOR AND DELIVERY UNSPECIFIED AS TO EPISODE OF CARE

668.11 CARDIAC COMPLICATIONS OF ANESTHESIA OR OTHER SEDATION IN LABOR AND DELIVERY DELIVERED

668.12 CARDIAC COMPLICATIONS OF ANESTHESIA OR OTHER SEDATION IN LABOR AND DELIVERY DELIVERED WITH POSTPARTUM COMPLICATION

668.13 CARDIAC COMPLICATIONS OF ANESTHESIA OR OTHER SEDATION IN LABOR AND DELIVERY ANTEPARTUM

668.14 CARDIAC COMPLICATIONS OF ANESTHESIA OR OTHER SEDATION IN LABOR AND DELIVERY POSTPARTUM

710.0 SYSTEMIC LUPUS ERYTHEMATOSUS

710.1 SYSTEMIC SCLEROSIS

710.2 SICCA SYNDROME

710.3 DERMATOMYOSITIS

710.4 POLYMYOSITIS

710.5 EOSINOPHILIA MYALGIA SYNDROME

710.8 OTHER SPECIFIED DIFFUSE DISEASES OF CONNECTIVE TISSUE

710.9 UNSPECIFIED DIFFUSE CONNECTIVE TISSUE DISEASE

714.0 RHEUMATOID ARTHRITIS

714.1 FELTY'S SYNDROME

714.2 OTHER RHEUMATOID ARTHRITIS WITH VISCERAL OR SYSTEMIC INVOLVEMENT

714.30 CHRONIC OR UNSPECIFIED POLYARTICULAR JUVENILE RHEUMATOID ARTHRITIS

714.31 ACUTE POLYARTICULAR JUVENILE RHEUMATOID ARTHRITIS

714.32 PAUCIARTICULAR JUVENILE RHEUMATOID ARTHRITIS

714.33 MONOARTICULAR JUVENILE RHEUMATOID ARTHRITIS

714.4 CHRONIC POSTRHEUMATIC ARTHROPATHY

714.81 RHEUMATOID LUNG

714.89 OTHER SPECIFIED INFLAMMATORY POLYARTHROPATHIES

714.9 UNSPECIFIED INFLAMMATORY POLYARTHROPATHY

729.5 PAIN IN LIMB

745.0 COMMON TRUNCUS

745.10 COMPLETE TRANSPOSITION OF GREAT VESSELS

745.11 DOUBLE OUTLET RIGHT VENTRICLE

745.12 CORRECTED TRANSPOSITION OF GREAT VESSELS

745.19 OTHER TRANSPOSITION OF GREAT VESSELS

745.2 TETRALOGY OF FALLOT

745.3 COMMON VENTRICLE

745.4 VENTRICULAR SEPTAL DEFECT

745.5 OSTIUM SECUNDUM TYPE ATRIAL SEPTAL DEFECT

745.60 ENDOCARDIAL CUSHION DEFECT UNSPECIFIED TYPE

745.61 OSTIUM PRIMUM DEFECT

745.69 OTHER ENDOCARDIAL CUSHION DEFECTS

745.7 COR BILOCULARE

745.8 OTHER BULBUS CORDIS ANOMALIES AND ANOMALIES OF CARDIAC SEPTAL CLOSURE

745.9 UNSPECIFIED DEFECT OF SEPTAL CLOSURE

746.00 CONGENITAL PULMONARY VALVE ANOMALY UNSPECIFIED

746.01 ATRESIA OF PULMONARY VALVE CONGENITAL

746.02 STENOSIS OF PULMONARY VALVE CONGENITAL

746.09 OTHER CONGENITAL ANOMALIES OF PULMONARY VALVE

746.1 TRICUSPID ATRESIA AND STENOSIS CONGENITAL

746.2 EBSTEIN'S ANOMALY

746.3 CONGENITAL STENOSIS OF AORTIC VALVE

746.4 CONGENITAL INSUFFICIENCY OF AORTIC VALVE

746.5 CONGENITAL MITRAL STENOSIS

746.6 CONGENITAL MITRAL INSUFFICIENCY

746.7 HYPOPLASTIC LEFT HEART SYNDROME

746.81 SUBAORTIC STENOSIS CONGENITAL

746.82 COR TRIATRIATUM

746.83 INFUNDIBULAR PULMONIC STENOSIS CONGENITAL

746.84 CONGENITAL OBSTRUCTIVE ANOMALIES OF HEART NOT ELSEWHERE CLASSIFIED

746.85 CORONARY ARTERY ANOMALY CONGENITAL

746.86 CONGENITAL HEART BLOCK

746.87 MALPOSITION OF HEART AND CARDIAC APEX

746.89 OTHER SPECIFIED CONGENITAL ANOMALIES OF HEART

746.9 UNSPECIFIED CONGENITAL ANOMALY OF HEART

747.0 PATENT DUCTUS ARTERIOSUS

747.10 COARCTATION OF AORTA (PREDUCTAL) (POSTDUCTAL)

747.11 INTERRUPTION OF AORTIC ARCH

747.20 CONGENITAL ANOMALY OF AORTA UNSPECIFIED

747.21 CONGENITAL ANOMALIES OF AORTIC ARCH

747.22 CONGENITAL ATRESIA AND STENOSIS OF AORTA

747.29 OTHER CONGENITAL ANOMALIES OF AORTA

747.3 CONGENITAL ANOMALIES OF PULMONARY ARTERY

747.40 CONGENITAL ANOMALY OF GREAT VEINS UNSPECIFIED

747.41 TOTAL ANOMALOUS PULMONARY VENOUS CONNECTION

747.42 PARTIAL ANOMALOUS PULMONARY VENOUS CONNECTION

747.49 OTHER ANOMALIES OF GREAT VEINS

747.5 ABSENCE OR HYPOPLASIA OF UMBILICAL ARTERY

747.60 ANOMALY OF THE PERIPHERAL VASCULAR SYSTEM UNSPECIFIED SITE

747.61 GASTROINTESTINAL VESSEL ANOMALY

747.62 RENAL VESSEL ANOMALY

747.63 UPPER LIMB VESSEL ANOMALY

747.64 LOWER LIMB VESSEL ANOMALY

747.69 ANOMALIES OF OTHER SPECIFIED SITES OF PERIPHERAL VASCULAR SYSTEM

747.81 CONGENITAL ANOMALIES OF CEREBROVASCULAR SYSTEM

747.82 SPINAL VESSEL ANOLMALY

747.83 PERSISTENT FETAL CIRCULATION

747.89 OTHER SPECIFIED CONGENITAL ANOMALIES OF CIRCULATORY SYSTEM

747.9 UNSPECIFIED CONGENITAL ANOMALY OF CIRCULATORY SYSTEM

780.02 TRANSIENT ALTERATION OF AWARENESS

780.2 SYNCOPE AND COLLAPSE

780.31 FEBRILE CONVULSIONS (SIMPLE), UNSPECIFIED

780.32 COMPLEX FEBRILE CONVULSIONS

780.33 POST TRAUMATIC SEIZURES

780.39 OTHER CONVULSIONS

780.4 DIZZINESS AND GIDDINESS

780.79 OTHER MALAISE AND FATIGUE

782.0 DISTURBANCE OF SKIN SENSATION

782.61 PALLOR

782.62 FLUSHING

785.0 TACHYCARDIA UNSPECIFIED

785.1 PALPITATIONS

785.2 UNDIAGNOSED CARDIAC MURMURS

785.3 OTHER ABNORMAL HEART SOUNDS

785.50 SHOCK UNSPECIFIED

785.51 CARDIOGENIC SHOCK

785.52 SEPTIC SHOCK

785.59 OTHER SHOCK WITHOUT TRAUMA

786.00 RESPIRATORY ABNORMALITY UNSPECIFIED

786.01 HYPERVENTILATION

786.02 ORTHOPNEA

786.03 APNEA

786.04 CHEYNE-STOKES RESPIRATION

786.05 SHORTNESS OF BREATH

786.06 TACHYPNEA

786.07 WHEEZING

786.09 RESPIRATORY ABNORMALITY OTHER

786.50 UNSPECIFIED CHEST PAIN

786.51 PRECORDIAL PAIN

786.52 PAINFUL RESPIRATION

786.59 OTHER CHEST PAIN

786.6 SWELLING MASS OR LUMP IN CHEST

789.01 ABDOMINAL PAIN RIGHT UPPER QUADRANT

789.02 ABDOMINAL PAIN LEFT UPPER QUADRANT

789.06 ABDOMINAL PAIN EPIGASTRIC

794.30 UNSPECIFIED ABNORMAL FUNCTION STUDY OF CARDIOVASCULAR SYSTEM

794.31 NONSPECIFIC ABNORMAL ELECTROCARDIOGRAM (ECG) (EKG)

794.39 OTHER NONSPECIFIC ABNORMAL FUNCTION STUDY OF CARDIOVASCULAR SYSTEM

799.01 ASPHYXIA

799.02 HYPOXEMIA

799.1 RESPIRATORY ARREST

860.0 TRAUMATIC PNEUMOTHORAX WITHOUT OPEN WOUND INTO THORAX

860.1 TRAUMATIC PNEUMOTHORAX WITH OPEN WOUND INTO THORAX

860.2 TRAUMATIC HEMOTHORAX WITHOUT OPEN WOUND INTO THORAX

860.3 TRAUMATIC HEMOTHORAX WITH OPEN WOUND INTO THORAX

860.4 TRAUMATIC PNEUMOHEMOTHORAX WITHOUT OPEN WOUND INTO THORAX

860.5 TRAUMATIC PNEUMOHEMOTHORAX WITH OPEN WOUND INTO THORAX

861.00 UNSPECIFIED INJURY OF HEART WITHOUT OPEN WOUND INTO THORAX

861.01 CONTUSION OF HEART WITHOUT OPEN WOUND INTO THORAX

861.02 LACERATION OF HEART WITHOUT PENETRATION OF HEART CHAMBERS OR OPEN WOUND INTO THORAX

861.03 LACERATION OF HEART WITH PENETRATION OF HEART CHAMBERS WITHOUT OPEN WOUND INTO THORAX

861.10 UNSPECIFIED INJURY OF HEART WITH OPEN WOUND INTO THORAX

861.11 CONTUSION OF HEART WITH OPEN WOUND INTO THORAX

861.12 LACERATION OF HEART WITHOUT PENETRATION OF HEART CHAMBERS WITH OPEN WOUND INTO THORAX

861.13 LACERATION OF HEART WITH PENETRATION OF HEART CHAMBERS AND OPEN WOUND INTO THORAX

861.20 UNSPECIFIED INJURY OF LUNG WITHOUT OPEN WOUND INTO THORAX

861.21 CONTUSION OF LUNG WITHOUT OPEN WOUND INTO THORAX

861.22 LACERATION OF LUNG WITHOUT OPEN WOUND INTO THORAX

861.30 UNSPECIFIED INJURY OF LUNG WITH OPEN WOUND INTO THORAX

861.31 CONTUSION OF LUNG WITH OPEN WOUND INTO THORAX

861.32 LACERATION OF LUNG WITH OPEN WOUND INTO THORAX

959.11 OTHER INJURY OF CHEST WALL

959.12 OTHER INJURY OF ABDOMEN

959.13 FRACTURE OF CORPUS CAVERNOSUM PENIS

959.14 OTHER INJURY OF EXTERNAL GENITALS

959.19 OTHER AND UNSPECIFIED INJURY OF OTHER SITES OF TRUNK

972.0 POISONING BY CARDIAC RHYTHM REGULATORS

972.1 POISONING BY CARDIOTONIC GLYCOSIDES AND DRUGS OF SIMILAR ACTION

972.2 POISONING BY ANTILIPEMIC AND ANTIARTERIOSCLEROTIC DRUGS

972.3 POISONING BY GANGLION-BLOCKING AGENTS

972.4 POISONING BY CORONARY VASODILATORS

972.5 POISONING BY OTHER VASODILATORS

972.6 POISONING BY OTHER ANTIHYPERTENSIVE AGENTS

972.7 POISONING BY ANTIVARICOSE DRUGS INCLUDING SCLEROSING AGENTS

972.8 POISONING BY CAPILLARY-ACTIVE DRUGS

972.9 POISONING BY OTHER AND UNSPECIFIED AGENTS PRIMARILY AFFECTING THE CARDIOVASCULAR SYSTEM

980.0 TOXIC EFFECT OF ETHYL ALCOHOL

980.1 TOXIC EFFECT OF METHYL ALCOHOL

980.2 TOXIC EFFECT OF ISOPROPYL ALCOHOL

980.3 TOXIC EFFECT OF FUSEL OIL

980.8 TOXIC EFFECT OF OTHER SPECIFIED ALCOHOLS

980.9 TOXIC EFFECT OF UNSPECIFIED ALCOHOL

981 TOXIC EFFECT OF PETROLEUM PRODUCTS

982.0 TOXIC EFFECT OF BENZENE AND HOMOLOGUES

982.1 TOXIC EFFECT OF CARBON TETRACHLORIDE

982.2 TOXIC EFFECT OF CARBON DISULFIDE

982.3 TOXIC EFFECT OF OTHER CHLORINATED HYDROCARBON SOLVENTS

982.4 TOXIC EFFECT OF NITROGLYCOL

982.8 TOXIC EFFECT OF OTHER NONPETROLEUM-BASED SOLVENTS

983.0 TOXIC EFFECT OF CORROSIVE AROMATICS

983.1 TOXIC EFFECT OF ACIDS

983.2 TOXIC EFFECT OF CAUSTIC ALKALIS

983.9 TOXIC EFFECT OF CAUSTIC UNSPECIFIED

984.0 TOXIC EFFECT OF INORGANIC LEAD COMPOUNDS

984.1 TOXIC EFFECT OF ORGANIC LEAD COMPOUNDS

984.8 TOXIC EFFECT OF OTHER LEAD COMPOUNDS

984.9 TOXIC EFFECT OF UNSPECIFIED LEAD COMPOUND

985.0 TOXIC EFFECT OF MERCURY AND ITS COMPOUNDS

985.1 TOXIC EFFECT OF ARSENIC AND ITS COMPOUNDS

985.2 TOXIC EFFECT OF MANGANESE AND ITS COMPOUNDS

985.3 TOXIC EFFECT OF BERYLLIUM AND ITS COMPOUNDS

985.4 TOXIC EFFECT OF ANTIMONY AND ITS COMPOUNDS

985.5 TOXIC EFFECT OF CADMIUM AND ITS COMPOUNDS

985.6 TOXIC EFFECT OF CHROMIUM

985.8 TOXIC EFFECT OF OTHER SPECIFIED METALS

985.9 TOXIC EFFECT OF UNSPECIFIED METAL

986 TOXIC EFFECT OF CARBON MONOXIDE

987.0 TOXIC EFFECT OF LIQUEFIED PETROLEUM GASES

987.1 TOXIC EFFECT OF OTHER HYDROCARBON GAS

987.2 TOXIC EFFECT OF NITROGEN OXIDES

987.3 TOXIC EFFECT OF SULFUR DIOXIDE

987.4 TOXIC EFFECT OF FREON

987.5 TOXIC EFFECT OF LACRIMOGENIC GAS

987.6 TOXIC EFFECT OF CHLORINE GAS

987.7 TOXIC EFFECT OF HYDROCYANIC ACID GAS

987.8 TOXIC EFFECT OF OTHER SPECIFIED GASES FUMES OR VAPORS

987.9 TOXIC EFFECT OF UNSPECIFIED GAS FUME OR VAPOR

988.0 TOXIC EFFECT OF FISH AND SHELLFISH EATEN AS FOOD

988.1 TOXIC EFFECT OF MUSHROOMS EATEN AS FOOD

988.2 TOXIC EFFECT OF BERRIES AND OTHER PLANTS EATEN AS FOOD

988.8 TOXIC EFFECT OF OTHER SPECIFIED NOXIOUS SUBSTANCES EATEN AS FOOD

988.9 TOXIC EFFECT OF UNSPECIFIED NOXIOUS SUBSTANCE EATEN AS FOOD

989.0 TOXIC EFFECT OF HYDROCYANIC ACID AND CYANIDES

989.1 TOXIC EFFECT OF STRYCHNINE AND SALTS

989.2 TOXIC EFFECT OF CHLORINATED HYDROCARBONS

989.3 TOXIC EFFECT OF ORGANOPHOSPHATE AND CARBAMATE

989.4 TOXIC EFFECT OF OTHER PESTICIDES NOT ELSEWHERE CLASSIFIED

989.5 TOXIC EFFECT OF VENOM

989.6 TOXIC EFFECT OF SOAPS AND DETERGENTS

989.7 TOXIC EFFECT OF AFLATOXIN AND OTHER MYCOTOXIN (FOOD CONTAMINANTS)

989.81 TOXIC EFFECT OF ASBESTOS

989.82 TOXIC EFFECT OF LATEX

989.83 TOXIC EFFECT OF SILICONE

989.84 TOXIC EFFECT OF TOBACCO

989.89 TOXIC EFFECT OF OTHER SUBSTANCE CHIEFLY NONMEDICINAL AS TO SOURCE NOT ELSEWHERE CLASSIFIED

989.9 TOXIC EFFECT OF UNSPECIFIED SUBSTANCE CHIEFLY NONMEDICINAL AS TO SOURCE

995.0 OTHER ANAPHYLACTIC SHOCK NOT ELSEWHERE CLASSIFIED

995.1 ANGIONEUROTIC EDEMA NOT ELSEWHERE CLASSIFIED

995.20 UNSPECIFIED ADVERSE EFFECT OF UNSPECIFIED DRUG, MEDICINAL AND BIOLOGICAL SUBSTANCE

995.21 ARTHUS PHENOMENON

995.22 UNSPECIFIED ADVERSE EFFECT OF ANESTHESIA

995.23 UNSPECIFIED ADVERSE EFFECT OF INSULIN

995.24 FAILED MODERATE SEDATION DURING PROCEDURE

995.27 OTHER DRUG ALLERGY

995.29 UNSPECIFIED ADVERSE EFFECT OF OTHER DRUG, MEDICINAL AND BIOLOGICAL SUBSTANCE

995.3 ALLERGY UNSPECIFIED NOT ELSEWHERE CLASSIFIED

995.4 SHOCK DUE TO ANESTHESIA NOT ELSEWHERE CLASSIFIED

995.50 UNSPECIFIED CHILD ABUSE

995.51 CHILD EMOTIONAL/PSYCHOLOGICAL ABUSE

995.52 CHILD NEGLECT (NUTRITIONAL)

995.53 CHILD SEXUAL ABUSE

995.54 CHILD PHYSICAL ABUSE

995.55 SHAKEN BABY SYNDROME

995.59 OTHER CHILD ABUSE AND NEGLECT

995.60 ANAPHYLACTIC SHOCK DUE TO UNSPECIFIED FOOD

995.61 ANAPHYLACTIC SHOCK DUE TO PEANUTS

995.62 ANAPHYLACTIC SHOCK DUE TO CRUSTACEANS

995.63 ANAPHYLACTIC SHOCK DUE TO FRUITS AND VEGETABLES

995.64 ANAPHYLACTIC SHOCK DUE TO TREE NUTS AND SEEDS

995.65 ANAPHYLACTIC SHOCK DUE TO FISH

995.66 ANAPHYLACTIC SHOCK DUE TO FOOD ADDITIVES

995.67 ANAPHYLACTIC SHOCK DUE TO MILK PRODUCTS

995.68 ANAPHYLACTIC SHOCK DUE TO EGGS

995.69 ANAPHYLACTIC SHOCK DUE TO OTHER SPECIFIED FOOD

995.7 OTHER ADVERSE FOOD REACTIONS NOT ELSEWHERE CLASSIFIED

995.80 UNSPECIFIED ADULT MALTREATMENT

995.81 ADULT PHYSICAL ABUSE

995.82 ADULT EMOTIONAL/PSYCHOLOGICAL ABUSE

995.83 ADULT SEXUAL ABUSE

995.84 ADULT NEGLECT (NUTRITIONAL)

995.85 OTHER ADULT ABUSE AND NEGLECT

995.86 MALIGNANT HYPERTHERMIA

995.89 OTHER SPECIFIED ADVERSE EFFECTS NOT ELSEWHERE CLASSIFIED

995.90 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME UNSPECIFIED

995.91 SEPSIS

995.92 SEVERE SEPSIS

995.93 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME DUE TO NONINFECTIOUS PROCESS WITHOUT ACUTE ORGAN DYSFUNCTION

995.94 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME DUE TO NONINFECTIOUS PROCESS WITH ACUTE ORGAN DYSFUNCTION

996.00 MECHANICAL COMPLICATIONS OF UNSPECIFIED CARDIAC DEVICE IMPLANT AND GRAFT

996.01 MECHANICAL COMPLICATION DUE TO CARDIAC PACEMAKER (ELECTRODE)

996.02 MECHANICAL COMPLICATION DUE TO HEART VALVE PROSTHESIS

996.03 MECHANICAL COMPLICATION DUE TO CORONARY BYPASS GRAFT

996.04 MECHANICAL COMPLICATION OF AUTOMATIC IMPLANTABLE CARDIAC DEFIBRILLATOR

996.09 OTHER MECHANICAL COMPLICATION OF CARDIAC DEVICE IMPLANT AND GRAFT

996.80 COMPLICATIONS OF UNSPECIFIED TRANSPLANTED ORGAN

996.81 COMPLICATIONS OF TRANSPLANTED KIDNEY

996.82 COMPLICATIONS OF TRANSPLANTED LIVER

996.83 COMPLICATIONS OF TRANSPLANTED HEART

996.84 COMPLICATIONS OF TRANSPLANTED LUNG

996.85 COMPLICATIONS OF TRANSPLANTED BONE MARROW

996.86 COMPLICATIONS OF TRANSPLANTED PANCREAS

996.87 COMPLICATIONS OF TRANSPLANTED ORGAN INTESTINE

996.89 COMPLICATIONS OF OTHER SPECIFIED TRANSPLANTED ORGAN

997.1 CARDIAC COMPLICATIONS NOT ELSEWHERE CLASSIFIED

997.2 PERIPHERAL VASCULAR COMPLICATIONS NOT ELSEWHERE CLASSIFIED

997.39 OTHER RESPIRATORY COMPLICATIONS

E933.1* ANTINEOPLASTIC AND IMMUNOSUPPRESSIVE DRUGS CAUSING ADVERSE EFFECTS IN THERAPEUTIC USE

E936.0* OXAZOLIDINE DERIVATIVES CAUSING ADVERSE EFFECTS IN THERAPEUTIC USE

E936.1* HYDANTOIN DERIVATIVES CAUSING ADVERSE EFFECTS IN THERAPEUTIC USE

E936.2* SUCCINIMIDES CAUSING ADVERSE EFFECTS IN THERAPEUTIC USE

E936.3* OTHER AND UNSPECIFIED ANTICONVULSANTS CAUSING ADVERSE EFFECTS IN THERAPEUTIC USE

E939.0 ANTIDEPRESSANTS CAUSING ADVERSE EFFECTS IN THERAPEUTIC USE

E939.1 PHENOTHIAZINE-BASED TRANQUILIZERS CAUSING ADVERSE EFFECTS IN THERAPEUTIC USE

E939.2 BUTYROPHENONE-BASED TRANQUILIZERS CAUSING ADVERSE EFFECTS IN THERAPEUTIC USE

E939.3 OTHER ANTIPSYCHOTICS NEUROLEPTICS AND MAJOR TRANQUILIZERS CAUSING ADVERSE EFFECTS IN THERAPEUTIC USE

E939.4 BENZODIAZEPINE-BASED TRANQUILIZERS CAUSING ADVERSE EFFECTS IN THERAPEUTIC USE

E939.5 OTHER TRANQUILIZERS CAUSING ADVERSE EFFECTS IN THERAPEUTIC USE

E939.6 PSYCHODYSLEPTICS (HALLUCINOGENS) CAUSING ADVERSE EFFECTS IN THERAPEUTIC USE

E939.7 PSYCHOSTIMULANTS CAUSING ADVERSE EFFECTS IN THERAPEUTIC USE

E939.8 OTHER PSYCHOTROPIC AGENTS CAUSING ADVERSE EFFECTS IN THERAPEUTIC USE

E939.9* UNSPECIFIED PSYCHOTROPIC AGENT CAUSING ADVERSE EFFECTS IN THERAPEUTIC USE

V45.01* CARDIAC PACEMAKER IN SITU

V45.02* AUTOMATIC IMPLANTABLE CARDIAC DEFIBRILLATOR IN SITU

V45.09* OTHER SPECIFIED CARDIAC DEVICE IN SITU

V45.81* POSTSURGICAL AORTOCORONARY BYPASS STATUS

V45.82* PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY STATUS

V58.69* LONG-TERM (CURRENT) USE OF OTHER MEDICATIONS

V58.83 ENCOUNTER FOR THERAPEUTIC DRUG MONITORING

V72.81 PRE-OPERATIVE CARDIOVASCULAR EXAMINATION

* According to the ICD-9-CM book, diagnosis codes E933.1, E936.0-E936.3, E939.0-E939.9, V45.01, V45.02, V45.09, V45.81, V45.82 and V58.69 are secondary diagnosis codes and should not be billed as the primary diagnosis.

 

 

Documentation Requirements

 

• In order to be covered and reimbursed by Medicare, a service must meet several requirements.

o It must fall within a defined benefit category, it cannot be excluded from coverage, either by statute or policy, and it must be medically necessary.

o Section 1862(a)(1)(a) of the Social Security Act precludes program payment for services not deemed to be medically necessary.

o This section of the Act underpins all Medicare regulations.

o Any document issued by CMS or any of its contractors, which contains statements regarding criteria for coverage and payment of any service (office visits, procedures, diagnostic tests, etc.) has as an underlying assumption that the service must comply with the requirements of §1862(a)(1)(a).

o The law states that the test cannot be reimbursed if it is not medically reasonable and necessary.

o As a consequence, it is incumbent upon the providers to be sure the service they provide is medically necessary, even in the instance where the documentation that proves medical necessity is created and/or housed by an entity other than the performing provider.

• It is also important to recognize that medical necessity is not met simply by merely matching a procedure code to a diagnosis code, as may be listed in a policy.

o In the case of a diagnostic test, it may be medically necessary in some instances but not in others; or it may be medically necessary at some point in the treatment of the beneficiary but not at others.

o Otherwise stated, it is not enough to only link a procedure code to a correct, payable diagnosis code – the test must be appropriate and medically necessary at the time and point at which it is being performed in the course of the patient’s evaluation.

o Furthermore, the Code of Federal Regulations (CFR), Title 42, part 410.32, specifies that all diagnostic tests must be ordered by a provider who is the treating provider for the patient and who will use the test results in the patient’s care.

o Tests not ordered by the physician who is treating the beneficiary are not reasonable and necessary.

• Like with any service reimbursed by Medicare, to support medical necessity there must be documentation in the medical record as to why a certain modality was chosen/performed.

o This entire documentation – not just the test report or the finding/diagnosis on the order – must be available for review in order to establish medical reasonableness and necessity by Medicare’s criteria.

• The EKG strip and a copy of the test results should be maintained in the medical record.

o In addition, the medical record must support that the physician interpreted and agrees with the test results and show that the results are being used to manage the patient.

• If the provider of service is other than the ordering/referring physician, that provider must maintain hard copy documentation of test results and interpretation, along with copies of the ordering/referring physician’s order for the studies.

o The physician must state the clinical indication/medical necessity for the study in the order for the test.

 

 

Treatment Logic

 

• An electrocardiogram (EKG) is a graphic representation of electrical activity within the heart.

• Electrodes placed on the body in predetermined locations sense this electrical activity, which is then recorded by various means for review and interpretation.

• EKG recordings are used to diagnose a wide range of heart disease and other conditions that manifest themselves by abnormal cardiac electrical activity.

 

 

Sources of Information and Basis for Decision

 

FCSO LCD 29163, Electrocardiography. 10/01/2010. The official local coverage determination (LCD) is the version on the Medicare coverage database at www.cms.gov/medicare-coverage-database/.

 

Hurst, J.W. (2003). Current status of clinical electrocardiography with suggestions for the improvement of the interpretive process. The American Journal of Cardiology, 92, 1072-1079.

 

Lee, T.H. (2001). Electrocardiography: ACC/AHA guidelines summary. In Braunwald: Heart Disease: A Textbook of Cardiovascular Medicine, Vol. 101, No. 101.

 

U.S. Preventative Services Task Force (2004). Screening for Coronary Heart Disease: Recommendation statement. (Annals of internal medicine, Volume 40 No. 7). Retrieved from www.anals.org on June 3, 2005.

 

 

AMA CPT / ADA CDT Copyright Statement

 

CPT codes, descriptions and other data only are copyright 2011 American Medical Association (or such other date of publication of CPT). All Rights Reserved. Applicable FARS/DFARS Clauses Apply. Current Dental Terminology, (CDT) (including procedure codes, nomenclature, descriptors and other data contained therein) is copyright by the American Dental Association. © 2002, 2004 American Dental Association. All rights reserved. Applicable FARS/DFARS apply.

 

 

Local Coverage Determination (LCD) Electrocardiography (L29163)